Concepedia

Author

Michelle Melisko

University of California, San FranciscoORCID

Also Known As

Athena Breast Health Network Investigators and Advocate Partners, Barbara Haley, Lin, Nancy U., M Melisko, M. E. Melisko, M. Melisko, Mead-Harvey, Carolyn, Melisko, Michelle, Melisko, Michelle E., Michelle E Melisko

334

Publications

11.1K

Citations

52

H-Index

172

Concepts

All Affiliations

University of California, San FranciscoUCSF Helen Diller Family Comprehensive Cancer CenterUniversity of Alabama at BirminghamThe University of Texas MD Anderson Cancer CenterMoffitt Cancer Center
MM

About

Michelle Melisko is an author at University of California, San Francisco specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

31

65

3K

2

Nursing

16

17

893

3

Health Sciences

14

15

522

4

Public Health

11

12

500

5

Education

2

2

180

Michelle Melisko

×

120

Publications

10.1K

Citations

50

H-Index

YearCitations

Fully Automated Echocardiogram Interpretation in Clinical Practice

Jeffrey Zhang, Sravani Gajjala, Pulkit Agrawal,

Circulation

2018

917

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

Rita Nanda, Minetta C. Liu, Christina Yau,

JAMA Oncology

2020

672

Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer

Joseph M. Letourneau, E. Ebbel, Patricia Katz,

Cancer

2011

540

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Nadine Tung, Mark E. Robson, Steffen Ventz,

Journal of Clinical Oncology

2020

471

Adaptive Randomization of Neratinib in Early Breast Cancer

John W. Park, Minetta C. Liu, Douglas Yee,

New England Journal of Medicine

2016

453

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

Pamela N. Münster, Kenneth T. Thurn, Scott Thomas,

British Journal of Cancer

2011

386

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Rachel A. Freedman, Rebecca Gelman, Carey K. Anders,

Journal of Clinical Oncology

2019

332

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Lajos Pusztai, Christina Yau, Denise M. Wolf,

Cancer Cell

2021

300

Acute ovarian failure underestimates age‐specific reproductive impairment for young women undergoing chemotherapy for cancer

Joseph M. Letourneau, E. Ebbel, Patricia Katz,

Cancer

2011

219

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

Douglas Yee, Angela DeMichele, Christina Yau,

JAMA Oncology

2020

207

Page 1